×
0 0 0 -0.0330578512396695 -0.251239669421488 -0.328479338842975 -0.315702479338843 -0.309090909090909
Stock impact report

Immuron up 11% on encouraging Travelan data [Seeking Alpha]

Immuron Ltd ADR (IMRN)  More Company Research Source: Seeking Alpha
US:NASDAQ Investor Relations: immuron.com/investor-centre/business-overview
PDF Immuron up 11% on encouraging Travelan data Thinly traded nano cap Immuron Limited ( IMRN +11.4% encouraging results Shigella 12 juvenile rhesus monkeys were segregated into two groups, eight who received Travalen and four who received placebo prior to oral challenge with All four monkeys in the placebo group developed acute dysentery within 24 - 36 hours of Six of the eight monkeys in the Travalen group showed no signs of dysentery while two "displayed" signs of dysentery. The results were reported by Bangkok, Thailand-based U.S. Armed Forces Research Institute of Medical Sciences, a laboratory of the Walter Reed Army Institute of Research. The active ingredient in Enterotoxigenic E. coli, Salmonella [Read more]
Impact snapshot Event time: IMRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
IMRN alerts
from News Quantified
Opt-in for
IMRN alerts

from News Quantified
Opt-in for
IMRN alerts

from News Quantified